| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/10/2002 | CA2415108A1 Culturing pancreatic stem cells having a specified, intermediate stage of development |
| 01/10/2002 | CA2414995A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | CA2414727A1 Elicitor from cladosporium |
| 01/10/2002 | CA2414672A1 Novel human serine-threonine kinase |
| 01/10/2002 | CA2414596A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | CA2414592A1 Calpain protease 12 |
| 01/10/2002 | CA2414497A1 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 01/10/2002 | CA2414328A1 Chimeric promoters for controlling expression in smooth muscle cells |
| 01/10/2002 | CA2413756A1 Dna encoding human serine protease d-g |
| 01/10/2002 | CA2413715A1 Grf2-binding proteins and applications thereof |
| 01/10/2002 | CA2413262A1 B7-like molecules and uses thereof |
| 01/10/2002 | CA2413237A1 Alteration of cell membrane for new functions |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413158A1 Ecm-related tumor marker |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412925A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 01/10/2002 | CA2412882A1 Peptide extended glycosylated polypeptides |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2410953A1 Adenylyl and guanylyl cyclases |
| 01/10/2002 | CA2410679A1 Secretion and trafficking molecules |
| 01/10/2002 | CA2407910A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1170592A1 Presentation of hydrophobic antigens to T-cells by CD1 molecules |
| 01/09/2002 | EP1170380A2 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 01/09/2002 | EP1170371A1 Phosphohexuloisomerase and gene therefor |
| 01/09/2002 | EP1170367A1 BVDV virus-like particles |
| 01/09/2002 | EP1170364A1 Mutations of cryptic splice sites in Cre and Cre-fusion proteins to improve the expression in inducibility |
| 01/09/2002 | EP1170363A1 Virus envelope vector for gene transfer |
| 01/09/2002 | EP1169481A1 Method of identifying toxic agents using differential gene expression |
| 01/09/2002 | EP1169472A2 Compound assay using nematodes |
| 01/09/2002 | EP1169469A1 Human colon cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1169463A1 Method for conveying bnyvv resistance to sugar beet plants |
| 01/09/2002 | EP1169459A1 Dsp-9 dual-specificity map kinase phosphatase |
| 01/09/2002 | EP1169456A1 Recombinant toxin a/toxin b vaccine against clostridium difficile |
| 01/09/2002 | EP1169455A1 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 01/09/2002 | EP1169451A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 01/09/2002 | EP1169448A1 Tumor necrosis factor homologs and nucleic acids encoding the same |
| 01/09/2002 | EP1169447A1 Genes and expression products from hematopoietic cells |
| 01/09/2002 | EP1169446A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 01/09/2002 | EP1169445A2 Human proteins and polynucleotides encoding them |
| 01/09/2002 | EP1169444A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2002 | EP1169443A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21 |
| 01/09/2002 | EP1169442A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2002 | EP1169440A1 48 human secreted proteins |
| 01/09/2002 | EP1169439A1 Combinatorial method for producing nucleic acids |
| 01/09/2002 | EP1169437A1 Noninvasive detection of colorectal cancer and other gastrointestinal pathology |
| 01/09/2002 | EP1169434A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 01/09/2002 | EP1169378A1 Preparing porous hydrogel products |
| 01/09/2002 | EP1169352A1 Erythropoietin receptor antibodies |
| 01/09/2002 | EP1169350A2 Human obesity protein binding protein-2 homolog compositions and uses thereof |
| 01/09/2002 | EP1169348A1 Purposeful movement of human migratory cells away from an agent source |
| 01/09/2002 | EP1169347A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/09/2002 | EP1169346A1 48 human secreted proteins |
| 01/09/2002 | EP1169345A2 Genes associated with diseases of the kidney |
| 01/09/2002 | EP1169344A1 47 human secreted proteins |
| 01/09/2002 | EP1169343A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 01/09/2002 | EP1169342A2 Tuberculosis antigens and methods of use therefor |
| 01/09/2002 | EP1169334A1 48 human secreted proteins |
| 01/09/2002 | EP1169333A1 49 human secreted proteins |
| 01/09/2002 | EP1169045A2 Immunomodulating polymers |
| 01/09/2002 | EP1168924A1 In vitro induction of antigen-specific t-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens |
| 01/09/2002 | EP1168919A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
| 01/09/2002 | EP1168918A1 Vaccines and gene therapy compositions and methods of making and using the same |
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1012237A4 Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase |
| 01/09/2002 | EP1009812A4 Transgenic plants with tocopherol methyltransferase |
| 01/09/2002 | EP0984699A4 Method of inhibiting immune system destruction of transplanted viable cells |
| 01/09/2002 | EP0929663A4 Method of increasing growth and yield in plants |
| 01/09/2002 | EP0873354A4 Novel amp activated protein kinase |
| 01/09/2002 | EP0714444B1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 01/09/2002 | CN1330720A Thioredoxin and grain processing |
| 01/09/2002 | CN1330718A Therapeutically active proteins in plants |
| 01/09/2002 | CN1330715A Selectively replicating viral vectors |
| 01/09/2002 | CN1330714A Virulence genes and proteins and their use |
| 01/09/2002 | CN1330665A Multiple domain glycoprotein hormones and methods of using |
| 01/09/2002 | CN1330664A Platelet-derived growth factor C, DNA coding therefor and uses thereof |
| 01/09/2002 | CN1330662A Heliobacter pylori antigen |
| 01/09/2002 | CN1330621A Method of vitamin production |
| 01/09/2002 | CN1330555A Antibodies to truncated VEGF-D and uses thereof |
| 01/09/2002 | CN1330142A Method for exosomatic separation and amplification of filled stem cells between human marrow and funic blood and directional induction toward nerve cells |
| 01/09/2002 | CN1330141A Gas circulation process for culturing plant cells |
| 01/09/2002 | CN1077438C Recombinant coccidiosis vaccines |
| 01/08/2002 | US6337391 Polycation-sensing receptor in aquatic species and methods of use |
| 01/08/2002 | US6337214 Detection of DNA, RNA and proteins using a test column with two snares |
| 01/08/2002 | US6337209 Molecular constructs containing a carcinoembryonic antigen regulatory sequence |
| 01/08/2002 | US6337198 Porous polymer scaffolds for tissue engineering |
| 01/08/2002 | US6337184 Detecting expression of a gene operatively linked to bcl-2, an apoptosis inhibition protein, within myogenic cells, as an indication the the myogenic cell is a muscle stem cell |
| 01/08/2002 | US6337088 Selecting a bacteriophage having dimensions similar to virus; loading bacteriophage into jacket comprising hollow fiber, sealing top and bottom ends, placing jacket into bath solution, inoculating lawn of bacteria, calculating retention |
| 01/08/2002 | CA2246222C Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 01/08/2002 | CA2166198C Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 01/08/2002 | CA2148138C Biological factors and neural stem cells |
| 01/08/2002 | CA2118113C Oil-body proteins as carriers of high-value peptides in plants |
| 01/08/2002 | CA2019559C Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof |
| 01/03/2002 | WO2002000921A1 Nutritional mixture and method for early identification and count of gram-negative organisms |
| 01/03/2002 | WO2002000907A1 Method for stable chromosomal multi-copy integration of genes |
| 01/03/2002 | WO2002000906A2 Replication deficient adenoviral tnf vector |
| 01/03/2002 | WO2002000904A2 Recombinant constructs and their use in reducing gene expression |
| 01/03/2002 | WO2002000899A2 Heterologous gene expression in plants |
| 01/03/2002 | WO2002000885A2 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 01/03/2002 | WO2002000883A2 Rescue of canine distemper virus from cdna |